ESPR
Esperion Therapeutics Inc
Price:  
2.63 
USD
Volume:  
2,507,996.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

ESPR WACC - Weighted Average Cost of Capital

The WACC of Esperion Therapeutics Inc (ESPR) is 6.2%.

The Cost of Equity of Esperion Therapeutics Inc (ESPR) is 8.10%.
The Cost of Debt of Esperion Therapeutics Inc (ESPR) is 5.00%.

Range Selected
Cost of equity 6.90% - 9.30% 8.10%
Tax rate 26.20% - 27.00% 26.60%
Cost of debt 5.00% - 5.00% 5.00%
WACC 5.6% - 6.9% 6.2%
WACC

ESPR WACC calculation

Category Low High
Long-term bond rate 4.2% 4.7%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.59 0.73
Additional risk adjustments 0.0% 0.5%
Cost of equity 6.90% 9.30%
Tax rate 26.20% 27.00%
Debt/Equity ratio 0.72 0.72
Cost of debt 5.00% 5.00%
After-tax WACC 5.6% 6.9%
Selected WACC 6.2%